0
Editor's Correspondence |

First-Generation vs Second-Generation Antihistamines

Gary G. Kay, PhD
Arch Intern Med. 1998;158(17):1949-1950. doi:.
Text Size: A A A
Published online

Extract

In reply

I appreciate the interest of Aelony in our study. His comments, however, suggest that he missed an important point of our article. Our study focused on determining the initial and steady-state effects of loratadine, a second-generation antihistamine, not demonstrating the well-established fact that diphenhydramine is a sedating drug. Prior to our study, there was only 1 other that reported on an investigation of the steady-state effects of loratadine on cognition, and that article is written in German.1 Diphenhydramine was included in our study as a positive-control substance. A positive control is used in pharmacological studies to demonstrate the sensitivity of the tests being used to measure the effect under investigation. If we had failed to demonstrate sedation with diphenhydramine, the sensitivity of our test battery would be called into question. The information that is considered useful to clinicians is not the fact that diphenhydramine is a sedating drug. Diphenhydramine is the most popular over-the-counter sleep aid! Rather, the information considered useful to clinicians was the finding that initial and steady-state doses of loratadine were no more sedating than placebo, and that its effects on measures of cognition, psychomotor performance, mood, and self-reported sleepiness were not different from those with placebo.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

September 28, 1998
Gary G. Kay, PhD
Arch Intern Med. 1998;158(17):1949-1950. doi:.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();